Estimating LDL Cholesterol in Metabolic Syndrome Patients
Author Information
Author(s): Gazi Irene, Tsimihodimos Vasilis, Filippatos Theodosios D, Saougos Vasilios G, Bairaktari Eleni T, Tselepis Alexandros D, Elisaf Moses
Primary Institution: University of Ioannina, Greece
Hypothesis
The study aims to evaluate the accuracy of various LDL cholesterol calculation formulas in patients with metabolic syndrome.
Conclusion
The Friedewald formula has limitations in estimating LDL cholesterol levels in patients with metabolic syndrome, while the Lipoprint LDL System may provide more accurate results.
Supporting Evidence
- LDL cholesterol levels were significantly different between metabolic syndrome and non-metabolic syndrome groups when calculated using certain formulas.
- The Friedewald formula showed limitations in accuracy for patients with metabolic syndrome.
- LDL cholesterol estimation by the Lipoprint LDL System may approach the accuracy of the gold standard method.
Takeaway
Doctors use different formulas to measure cholesterol, and this study found that one formula might not work well for people with metabolic syndrome, but another method could be better.
Methodology
The study involved 179 patients attending an outpatient lipid clinic, evaluating various LDL cholesterol estimation formulas and comparing their results.
Potential Biases
Potential biases exist in the LDL estimation formulas, particularly in patients with elevated triglyceride levels.
Limitations
The study's findings may not be applicable to all patient populations, and the Lipoprint LDL System is not intended for routine clinical use.
Participant Demographics
Patients were adults attending a lipid clinic, with some meeting the criteria for metabolic syndrome.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website